Skip to content

COMPARATIVE STUDY IN MANAGEMENT OF BRONCHIAL ASTHMA

"TO COMPARE THE EFFECTIVENESS OF INDIVIDUALISED HOMOEPATHIC MEDICINE VERSUS ARALIA RACEMOSA MOTHER TINCTURE IN MANAGEMENT OF BRONCHIAL ASTHMA- A SINGLE BLIND, RANDOMISED CONTROLLED TRIAL"

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/052016
Enrollment
60
Registered
2023-04-26
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J45- Asthma

Interventions

Intervention1: INDIVIDUALISED HOMOEOPATHIC MEDICINE: A COMPELETE DETAILED CASE TAKING AND REPERTORISATION WILL BE DONE ACCORDING TO HOMOEPATHIC PRINCIPLES AND PATIENT WILL RECIEVE INDIVIDUALISED HOMOE

Sponsors

NEHRU HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. patient having clinical sign and symptoms of bronchial asthma. 2.pre diagnosed cases of bronchial asthma 3.patient from 17-75 year of age. 4.patient of both sexes 5.patients on conventional treatment for bronchial asthma 6. patient giving informed consent

Exclusion criteria

Exclusion criteria: 1.patient suffering from severe persistent asthma2. 2.self reported immunocompromised cases 3.patient with serious illness or other uncontrolled life threatening condition 4.dagnosed cases of psychiatric illness 5. pregnant women and lactating mother 6.substance abuse/dependance 7. patient who are not willing to be a part of this study.

Design outcomes

Primary

MeasureTime frame
1.TO EVALUATE WHICH IS MORE EFFECTIVE i.e. INDIVIDUALISED HOMOEOPATHIC MEDICINE OR ARALIA RACEMOSA MOTHER TINCTURE IN MANAGEMENT OF BRONCHIAL ASTHMA 2. TO ASSESS THE IMPROVEMENT OF PATIENTS IN TERMS OF FREQUENCY OF ATTACK AND SEVERITY OF SYMPTOMS OF ASTHMA.Timepoint: INTIALLY AT BASE LINE AND THEN EVERY MONTH UPTO 1 YEAR .

Secondary

MeasureTime frame
1. TO ASSESS THE IMPROVEMENT IN SYMPTOMATOLOGY USING ACT SCORE 2. TO ASSESS THE QUALITY OF LIFE BY APPLYING AQLQ.Timepoint: INTIALLY AT BASE LINE AND THEN EVERY MONTH UPTO 1 YEAR

Countries

India

Contacts

Public ContactDR MANISHA

NEHRU HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITAL

drgeorgem@gmail.com7982783132

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026